BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10768570)

  • 1. Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
    Krishnamurthy GT; Krishnamurthy S
    J Nucl Med; 2000 Apr; 41(4):688-91. PubMed ID: 10768570
    [No Abstract]   [Full Text] [Related]  

  • 2. New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
    Williams JE
    J Nucl Med; 1997 Nov; 38(11):19N-20N, 26N. PubMed ID: 9374327
    [No Abstract]   [Full Text] [Related]  

  • 3. Pain palliation and nuclear medicine.
    McEwan AJ
    Eur J Nucl Med; 1993 Jan; 20(1):1-3. PubMed ID: 7678395
    [No Abstract]   [Full Text] [Related]  

  • 4. Samarium-153 lexidronam for painful bone metastases.
    Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radionuclide therapy for painful bone metastases].
    Szefer J; Zuchora Z
    Wiad Lek; 2004; 57(5-6):280-3. PubMed ID: 15518077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted radionuclide therapy for bone metastases.
    Lewington VJ
    Eur J Nucl Med; 1993 Jan; 20(1):66-74. PubMed ID: 7678397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESR dosimetry of 89Sr and 153Sm in bone.
    Kinoshita A; Braga FJ; Graeff CF; Baffa O
    Appl Radiat Isot; 2001 Feb; 54(2):269-74. PubMed ID: 11200888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [153Sm-EDTMP for moderate and severe bone cancer pain].
    Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
    Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G
    Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic radiotherapy: what role will it have in 2001?].
    George B; Douard MC; Rain JD
    Cancer Radiother; 2002 May; 6(3):188-200. PubMed ID: 12116845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiopharmaceuticals in clinical trials.
    Holmes RA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
    Serafini AN
    Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular radiotherapy.
    Buscombe J; Navalkissoor S
    Clin Med (Lond); 2012 Aug; 12(4):381-6. PubMed ID: 22930888
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
    Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
    Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
    Jiang CY; Zhu BL; Zhang YJ
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):118-21. PubMed ID: 7523052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsealed source therapy of painful bone metastases: an update.
    McEwan AJ
    Semin Nucl Med; 1997 Apr; 27(2):165-82. PubMed ID: 9144858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internally administered isotopes in the treatment of solid malignancy.
    Willett CG
    J Nucl Med; 1990 May; 31(5):601-2. PubMed ID: 2341895
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
    Badawi JK
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1645-9. PubMed ID: 22875692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nationally produced 153SmEDTMP in the palliative treatment of metastatic bone cancer pain].
    Olea E; Gil MC; Tomicic M; Araya G; Chandía M; Quintana JC; Pinto L; Orellana P; Nagel J; Ortíz V
    Rev Med Chil; 1996 Jul; 124(7):805-12. PubMed ID: 9138368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.